Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Severe α1-antitrypsin deficiency associated with lower blood pressure and reduced risk of ischemic heart disease: a cohort study of 91,540 individuals and a meta-analysis

Research output: Contribution to journalJournal articlepeer-review

  1. Unmet needs in pneumonia research: a comprehensive approach by the CAPNETZ study group

    Research output: Contribution to journalReviewpeer-review

  2. Validation of a derived version of the IPF-specific Saint George’s Respiratory Questionnaire

    Research output: Contribution to journalJournal articlepeer-review

  3. Long-term predictors of severe exacerbations and mortality in a cohort of well-characterised adults with asthma

    Research output: Contribution to journalJournal articlepeer-review

  4. Turnover of type I and III collagen predicts progression of idiopathic pulmonary fibrosis

    Research output: Contribution to journalJournal articlepeer-review

View graph of relations

BACKGROUND: Increased elastase activity in α1-antitrypsin deficiency may affect elasticity of the arterial walls, and thereby blood pressure and susceptibility to cardiovascular disease. We hypothesized that severe α1-antitrypsin deficiency is associated with reduced blood pressure and susceptibility to cardiovascular disease.

METHODS: We genotyped 91,353 adults randomly selected from the Danish general population and 187 patients from the Danish α1-Antitrypsin Deficiency Registry and recorded baseline blood pressure, baseline plasma lipids and cardiovascular events during follow-up. 185 participants carried the ZZ genotype, 207 carried the SZ genotype and 91,148 carried the MM genotype.

RESULTS: α1-Antitrypsin deficiency was associated with decreases in blood pressure of up to 5 mmHg for systolic blood pressure and up to 2 mmHg for diastolic blood pressure, in ZZ vs SZ vs MM individuals (trend test, P's ≤ 0.01). Plasma triglycerides and remnant cholesterol were reduced in ZZ individuals compared with MM individuals (t-test, P's < 0.001). α1-Antitrypsin deficiency was associated with lower risk of myocardial infarction (trend test P = 0.03), but not with ischemic heart disease, ischemic cerebrovascular disease or hypertension (trend test, P's ≥ 0.59). However, when results for ischemic heart disease were summarized in meta-analysis with results from four previous studies, individuals with versus without α1-antitrypsin deficiency had an odds ratio for ischemic heart disease of 0.66 (95% CI:0.53-0.84).

CONCLUSIONS: Individuals with severe α1-antitrypsin deficiency have lower systolic and diastolic blood pressure, lower plasma triglycerides and remnant cholesterol, reduced risk of myocardial infarction, and a 34% reduced risk of ischemic heart disease.

Original languageEnglish
Article number55
JournalRespiratory Research
Volume23
Issue number1
ISSN1465-9921
DOIs
Publication statusPublished - Dec 2022

Bibliographical note

Publisher Copyright:
© 2022, The Author(s).

    Research areas

  • Blood pressure, Cardiovascular disease, Epidemiology, Genetics, Lipids, SERPINA1, α-Antitrypsin deficiency

ID: 79243639